NanoString Technologies | NSTG - Capitale Ordinario



Capitale Ordinario Cambiamento Data
Agilent USD 282.7M 358K 2025-12
Becton, Dickinson and Co. USD 284.91M 1.72M 2025-12
Bio Techne USD 155.75M 154.18M 2025-09
Bio-Rad Laboratories USD 26.97M 90K 2025-09
Bruker USD 151.94M 225K 2025-12
Charles River Laboratories USD 49.22M 2K 2025-12
Danaher USD 707.7M 800K 2026-03
Illumina USD 152.8M 900K 2025-12
IQVIA Holdings USD 169.6M 700K 2025-12
Mettler Toledo International USD 20.43M 170.6K 2025-12
Myriad Genetics USD 93.5M 400K 2025-12
Pacific Biosciences Of California USD 301.96M 103K 2025-12
Repligen USD 56.32M 42K 2025-12
Revvity USD 113.38M 2.7M 2025-12
Roche Holding CHF 795.62M 699.54K 2025-12
Standard Biotools USD 386.38M 2.77M 2025-12
Thermo Fisher Scientific USD 371.62M 4.09M 2026-03
Waters USD 98.08M 38.55M 2025-12